Home › NDC Lookup › Ingredients › Calcium Carbonate › 11673-0547-54
Target Berry Lime HBG Chews calcium carbonate 80 mg; 750 mg Tablet, Chewable, 54-count — NDC 11673-0547-54 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Target Berry Lime HBG Chews calcium carbonate 80 mg; 750 mg Tablet, Chewable, 54-count — NDC 11673-547-54 (Billing 11673-0547-54)

by Target · 54 TABLET, CHEWABLE in 1 BOTTLE

This is a package of 54 tablets of Target Berry Lime HBG Chews calcium carbonate 80 mg; 750 mg Tablet, Chewable from Target, marketed since Feb 2024 and currently FDA-listed. It is this product's only package size.

NDC 11673-0547-54
🏷️ FDA NDC (as labeled) 11673-547-54 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 11673-547-54 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
11673 labeler · 547 product · 54 package
Package marketed since
Feb 22, 2024
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 1167354754 0
FDA record last changed
Aug 27, 2026
⚠️
Other active recalls for Calcium Carbonate (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · May 28, 2026 — Presence of foreign substance: small metallic particles in chewable tablets. (Guardian Drug Co. Inc.) · FDA recall D-0573-2026
Class II · May 28, 2026 — Presence of foreign substance: small metallic particles in chewable tablets. (Guardian Drug Co. Inc.) · FDA recall D-0561-2026
Class II · May 28, 2026 — Presence of foreign substance: small metallic particles in chewable tablets. (Guardian Drug Co. Inc.) · FDA recall D-0578-2026
Class II · May 28, 2026 — Presence of foreign substance: small metallic particles in chewable tablets. (Guardian Drug Co. Inc.) · FDA recall D-0568-2026
Class II · May 28, 2026 — Presence of foreign substance: small metallic particles in chewable tablets. (Guardian Drug Co. Inc.) · FDA recall D-0579-2026
Class II · May 28, 2026 — Presence of foreign substance: small metallic particles in chewable tablets. (Guardian Drug Co. Inc.) · FDA recall D-0560-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 11673-547-54
Product NDC 11673-547
11-digit billing NDC 11673054754
RxCUI 1492387
UNII 92RU3N3Y1O, H0G9379FGK
Application # M001
SPL Set ID 11fba65d-8a81-1227-e063-6294a90a11bd
Physiologic effect Skin Barrier Activity
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-02-22
Route ORAL
Dosage form TABLET, CHEWABLE
Substance DIMETHICONE; CALCIUM CARBONATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 41200030100920
GPI class TGT Allergy Relief Childrens
Quick answers
  • GPI-14 (Medi-Span): 41200030100920
  • RxCUI (RxNorm): 1492387
Why two NDCs? The FDA registers this code as 11673-547-54 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 11673-0547-54. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Calcium compounds class.

Drug family (ATC) Calcium compounds, Calcium
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • Most often it's an antacid. It relieves heartburn, acid indigestion, sour stomach and upset stomach tied to those symptoms. A few supplement products have other uses, like bone sup...
  • What is calcium carbonate usually used for?
  • You chew it when symptoms come on. Many labels say to chew or crush the tablets completely and not swallow them whole. The number of tablets varies by product, so read your label o...
  • Many labels say not to use the maximum dose for more than 2 weeks unless a doctor is supervising you. If your symptoms last longer than 2 weeks, check in with your doctor.
📖 Read our full Calcium Carbonate guide →
4
Nutrient depletion considerations

Calcium Carbonate may be associated with lower levels of 4 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Calcium Carbonate nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
11673-0547-54 You're viewing this Main listing 54 TABLET, CHEWABLE in 1 BOTTLE 2024-02-22 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Tums Chewy Bites with Gas Relief 750 mg/1; 80 mg 00135-0624-01 Haleon 28 tablets — — FDA listed —
Alka-Seltzer Kids Tummy ReliefChews 750 mg/1; 80 mg 00280-0051-01 Bayer 28 tablets — — FDA listed —
Alka-Seltzer Heartburn Plus Gas ReliefChews Tropical Punch 80 mg/1; 750 mg 00280-0225-01 Bayer 110 tablets — — FDA listed —
Walgreens Cherry Berry Lime Antacid HBG 54ct 750 mg/1; 80 mg 00363-9953-54 Walgreens 54 tablets — — FDA listed —
Target Antacid - Anti-Gas Relief Chews 80 mg/1; 750 mg 11673-0052-54 Target 54 tablets — — FDA listed —
Target Berry Lime HBG Chews 80 mg/1; 750 mgthis 11673-0547-54 Target 54 tablets — — FDA listed —
Mixed Berry Antacid and Anti-Gas Chews 80 mg/1; 750 mg 49035-0058-54 Walmart 54 tablets — — FDA listed —
CVS Mixed Berry Antacid HBG 54ct 750 mg/1; 80 mg 51316-0050-54 CVS 54 tablets — — FDA listed —
CVS Mixed Berry Antacid HBG 28ct 80 mg/1; 750 mg 51316-0051-28 CVS 28 tablets — — FDA listed —
Heartburn and gas fruit chews 80 mg/1; 750 mg 69842-0362-36 CVS 36 tablets — — FDA listed —
Basic Care Berry Antacid HBG 80 mg/1; 750 mg 72288-0235-82 Amazon.com 82 tablets — — FDA listed —
TopCare Cherry Berry Lime Antacid HBG 80 mg/1; 750 mg 76162-0408-54 TopCo 54 tablets — — FDA listed —
Meijer Berry Lime Antacid HBG Chews 750 mg/1; 80 mg 79481-0093-01 Meijer 54 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Feb 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

1 inactive ingredient listed in the exact product block matched to this NDC.

The official label also statesInactive ingredients: Beeswax, carmine, carnauba wax, corn syrup, dextrin, FD&C blue #1 aluminum lake, FD&C blue #2 aluminum lake, FD&C red #40 aluminum lake, FD&C yellow #5 aluminum lake, FD&C yellow #6 aluminum lake, gum arabic, hydrogenated coconut oil, maltodextrin, medium chain triglycerides, natural & artificial flavors, phosphoric acid, propylene glycol, shellac, sodium benzoate, sorbitol, soy lecithin, soybean oil, sucrose, titanium dioxide, water.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerTarget
FDA applicationM001 (OTC MONOGRAPH DRUG)
Labeler code11673
First marketedFeb 2024
Product typeHuman Otc Drug
Portfolio12 products on file

More NDCs from Target labeler code 11673

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Ask a Doctor or Pharmacist Before Use If 📄 When Using This Product 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 23 words ▾

Uses Relieves Heartburn Sour stomach Acid indigestion Upset stomach due to these symptoms Bloating, pressure or stuffed feeling commonly referred to as gas

⏱️ Dosage and Administration 37 words ▾

Directions Adults and children 12 years and older chew and swallow 1 to 2 chewable tablets every 2-4 hours as needed. Do not exceed 5 chewable tablets in 24 hours. Children under 12 years consult a doctor.

⚠️ Warnings 52 words ▾

Do not use if you have ever had an allergic reaction to this product or any of its ingredients. Do not take more than maximum dosage in a 24-hour period, or use the maximum dosage for this product for more than 2 weeks, except under the advice and supervision of a physician.

🧪 Active Ingredient 13 words ▾

Active ingredients (in each chewable tablet) Calcium carbonate 750 mg Simethicone 80 mg

🧪 Inactive Ingredients 63 words ▾

Inactive ingredients: Beeswax, carmine, carnauba wax, corn syrup, dextrin, FD&C blue #1 aluminum lake, FD&C blue #2 aluminum lake, FD&C red #40 aluminum lake, FD&C yellow #5 aluminum lake, FD&C yellow #6 aluminum lake, gum arabic, hydrogenated coconut oil, maltodextrin, medium chain triglycerides, natural & artificial flavors, phosphoric acid, propylene glycol, shellac, sodium benzoate, sorbitol, soy lecithin, soybean oil, sucrose, titanium dioxide, water.

🎯 Purpose 3 words ▾

Purpose Antacid Anti-gas

📄 Ask a Doctor or Pharmacist Before Use If 22 words ▾

Ask a doctor or pharmacist before use if you are now taking a prescription drug. Antacids may interact with certain prescription drugs.

📄 When Using This Product 7 words ▾

When using this product constipation may occur

🤰 If Pregnant or Breast-Feeding 10 words ▾

Of pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 6 words ▾

Keep out of reach of children.

📄 Other Information 33 words ▾

Other information Each chewable tablet contains: Calcium 300 mg Contains soy Contains FD&C yellow No. 5 (tartrazine) as a color additive Store between 20° to 25°C (68° to 77°F) in a dry place

📄 Questions or Comments 10 words ▾

Questions? Call 1-800-245-2898 Monday - Friday, 9AM - 4PM EST

📄 Package Label / Principal Display Panel 8 words ▾

Up & Up Cherry Berry Lime HBG 54ct

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Target Berry Lime HBG Chews (this brand).

Top reported reactions

Fatigue4,862
Nausea4,273
Pain4,068
Dyspnoea3,877
Diarrhoea3,719
Vomiting3,648
Pneumonia3,265

Age at onset

Neonate80
Infant20
Child108
Adolescent139
Adult3,532
Elderly3,644

Reporter sex

46,685 reports
Male · 32%
Female · 68%
Unknown · 0%

Serious outcomes

Hospitalization22,382
Death7,134
Life-threatening5,530
Disabling4,060
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 3,945 1,494
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Target. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Target is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 11673-0542-12 · Target 11673-0548-30 · Target →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.